发明名称 Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
摘要 The present invention provides fused heterocyclic derivatives represented by the following general formula (I) or pharmaceutically acceptable salts thereof, or prodrugs thereof, which exhibit an inhibitory activity in human SGLT and are useful as agents for the prevention or treatment of a disease associated with hyperglycemia such as diabetes, postprandial hyperglycemia, impaired glucose tolerance, diabetic complications or obesity, in the formula R<SUP>1 </SUP>to R<SUP>4 </SUP>represent H, OH, an amino group, etc.; R<SUP>5 </SUP>and R<SUP>6 </SUP>represent H, OH, a halogen atom, an option ally substituted alkyl group, etc.; Q represents alkylene, alkenylene, etc.; ring A represents an aryl group or a heteroaryl group; the following ring (R1) represents a group represented by the following ring (R2); G represents a group represented by the following general formula (G-1) or (G-2) (E<SUP>1 </SUP>represents H, F or OH; and E represents H, F, a methyl group, etc.), and pharmaceutical compositions comprising the same, and pharmaceutical uses thereof.
申请公布号 US2007197450(A1) 申请公布日期 2007.08.23
申请号 US20050591421 申请日期 2005.03.03
申请人 KISSEI PHARMACEUTICAL CO., LTD. 发明人 FUSHIMI NOBUHIKO;ISAJI MASAYUKI;FUJIKURA HIDEKI
分类号 A61K31/7052;A61K31/351;A61K31/381;A61K31/404;A61K45/00;A61K45/06;A61P3/04;A61P3/06;A61P3/10;A61P7/10;A61P9/04;A61P9/10;A61P9/12;A61P19/06;A61P43/00;C07D405/04;C07D407/04;C07D409/04;C07H17/02 主分类号 A61K31/7052
代理机构 代理人
主权项
地址
您可能感兴趣的专利